Intellipharmaceutics International Inc. (IPCIF)
OTCMKTS: IPCIF · Delayed Price · USD
0.150
+0.090 (150.00%)
Jul 26, 2024, 4:00 PM EDT - Market closed
IPCIF Employees
Intellipharmaceutics International had 11 employees as of November 30, 2022. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$82,268
Profits / Employee
-$288,528
Market Cap
360.62B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
IPCIF News
- 6 weeks ago - Intellipharmaceutics Announces Downgrade to OTC Expert Market - Accesswire
- 4 months ago - Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan - Accesswire
- 5 months ago - Intellipharmaceutics Announces Cease Trade Order - Accesswire
- 5 months ago - Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form - Accesswire
- 6 months ago - Intellipharmaceutics International Inc. Announces Stock Option Grant - Accesswire
- 7 months ago - Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange - Accesswire
- 10 months ago - Intellipharmaceutics Announces Third Quarter 2023 Results - Accesswire
- 11 months ago - Intellipharmaceutics Reports Director Election Results - Accesswire